Ruth Bevan

1.9k total citations
44 papers, 1.4k citations indexed

About

Ruth Bevan is a scholar working on Health, Toxicology and Mutagenesis, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ruth Bevan has authored 44 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Health, Toxicology and Mutagenesis, 13 papers in Cancer Research and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ruth Bevan's work include Carcinogens and Genotoxicity Assessment (13 papers), Occupational and environmental lung diseases (7 papers) and Effects and risks of endocrine disrupting chemicals (7 papers). Ruth Bevan is often cited by papers focused on Carcinogens and Genotoxicity Assessment (13 papers), Occupational and environmental lung diseases (7 papers) and Effects and risks of endocrine disrupting chemicals (7 papers). Ruth Bevan collaborates with scholars based in United Kingdom, Germany and United States. Ruth Bevan's co-authors include Kate Jones, Len Levy, John Cocker, Rebecca Slack, Helen R. Griffiths, Roel Smolders, Holger M. Koch, Nalini Mistry, Léa Fortunato and Martie van Tongeren and has published in prestigious journals such as Biochemical and Biophysical Research Communications, FEBS Letters and Free Radical Biology and Medicine.

In The Last Decade

Ruth Bevan

44 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruth Bevan United Kingdom 19 522 216 199 196 149 44 1.4k
Stefano Lorenzetti Italy 24 357 0.7× 82 0.4× 172 0.9× 323 1.6× 80 0.5× 63 1.4k
Javier Pintos Canada 24 425 0.8× 365 1.7× 200 1.0× 193 1.0× 47 0.3× 47 1.9k
Daniel Prá Brazil 22 236 0.5× 57 0.3× 195 1.0× 306 1.6× 207 1.4× 65 1.3k
Zhangjian Chen China 23 559 1.1× 112 0.5× 85 0.4× 285 1.5× 186 1.2× 69 1.8k
Ewa Jabłońska Poland 23 488 0.9× 263 1.2× 284 1.4× 565 2.9× 62 0.4× 158 2.6k
Stavros Sifakis Greece 31 821 1.6× 234 1.1× 238 1.2× 708 3.6× 76 0.5× 99 3.4k
Mya Swanson United States 29 410 0.8× 251 1.2× 355 1.8× 450 2.3× 248 1.7× 45 2.9k
Haji Bahadar Iran 15 511 1.0× 49 0.2× 139 0.7× 272 1.4× 108 0.7× 29 1.6k
Seong‐Kyu Kang South Korea 22 485 0.9× 228 1.1× 183 0.9× 74 0.4× 80 0.5× 120 1.5k
Zhong‐Ning Lin China 27 478 0.9× 177 0.8× 261 1.3× 684 3.5× 171 1.1× 62 1.9k

Countries citing papers authored by Ruth Bevan

Since Specialization
Citations

This map shows the geographic impact of Ruth Bevan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth Bevan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth Bevan more than expected).

Fields of papers citing papers by Ruth Bevan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruth Bevan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth Bevan. The network helps show where Ruth Bevan may publish in the future.

Co-authorship network of co-authors of Ruth Bevan

This figure shows the co-authorship network connecting the top 25 collaborators of Ruth Bevan. A scholar is included among the top collaborators of Ruth Bevan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruth Bevan. Ruth Bevan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bevan, Ruth & Len Levy. (2024). Biomonitoring for workplace exposure to copper and its compounds is currently not interpretable. International Journal of Hygiene and Environmental Health. 258. 114358–114358. 3 indexed citations
2.
Bevan, Ruth, et al.. (2019). Evaluating the risk to humans from mineral oils in foods: Current state of the evidence. Food and Chemical Toxicology. 136. 110966–110966. 10 indexed citations
4.
Bevan, Ruth, Reinhard Kreiling, Leonard S. Levy, & David B. Warheit. (2018). Toxicity testing of poorly soluble particles, lung overload and lung cancer. Regulatory Toxicology and Pharmacology. 100. 80–91. 31 indexed citations
6.
Bevan, Ruth, et al.. (2016). Setting evidence-based occupational exposure limits for manganese. NeuroToxicology. 58. 238–248. 18 indexed citations
7.
Harrison, Paul J., Philip Holmes, Ruth Bevan, et al.. (2015). Regulatory risk assessment approaches for synthetic mineral fibres. Regulatory Toxicology and Pharmacology. 73(1). 425–441. 28 indexed citations
8.
Koch, Holger M., Lesa L. Aylward, Sean M. Hays, et al.. (2014). Inter- and intra-individual variation in urinary biomarker concentrations over a 6-day sampling period. Part 2: Personal care product ingredients. Toxicology Letters. 231(2). 261–269. 99 indexed citations
9.
Bevan, Ruth, J. Angerer, John Cocker, et al.. (2012). Framework for the development and application of environmental biological monitoring guidance values. Regulatory Toxicology and Pharmacology. 63(3). 453–460. 15 indexed citations
10.
Bevan, Ruth, et al.. (2011). Public Health Impacts of Exposure to Carbon Monoxide From Gas Appliances in UK Homes – Are We Missing Something?. Indoor and Built Environment. 21(2). 229–240. 7 indexed citations
11.
Williams, Gail, Jeremy S. Caldwell, Donald Armstrong, et al.. (2008). Multicenter study to assess potential hazards from exposure to lipid peroxidation products in soya bean oil from Trilucent™ breast implants. Regulatory Toxicology and Pharmacology. 53(2). 107–120. 6 indexed citations
12.
Mistry, Nalini, Ruth Bevan, Marcus S. Cooke, et al.. (2008). Antiserum detection of reactive carbonyl species-modified DNA in human colonocytes. Free Radical Research. 42(4). 344–353. 4 indexed citations
13.
Griffiths, Helen R., et al.. (2008). In vivo vitamin C supplementation increases phosphoinositol transfer protein expression in peripheral blood mononuclear cells from healthy individuals. British Journal Of Nutrition. 101(10). 1432–1439. 13 indexed citations
15.
Bevan, Ruth, et al.. (2006). Evidence of oligonucleotides containing 8-hydroxy-2′-deoxyguanosine in human urine. Free Radical Biology and Medicine. 42(4). 552–558. 34 indexed citations
16.
Cooke, Marcus S., Nalini Mistry, Helen L. Waller, et al.. (2003). Deoxycytidine glyoxal: lesion induction and evidence of repair following vitamin C supplementation in vivo. Free Radical Biology and Medicine. 34(2). 218–225. 17 indexed citations
17.
Griffiths, Helen R., et al.. (1999). Oxidative modification of a specific apolipoprotein B lysine residue confers altered receptor specificity on LDL. Redox Report. 4(6). 337–339. 6 indexed citations
18.
Bevan, Ruth, et al.. (1998). Chemiluminescence determination of hydroperoxides following radiolysis and photolysis of free amino acids. FEBS Letters. 430(3). 297–300. 16 indexed citations
19.
Förster, L, et al.. (1997). Dietary vitamin E supplementation inhibits thrombin‐induced platelet aggregation, but not monocyte adhesiveness, in patients with hypercholesterolaemia. International Journal of Experimental Pathology. 78(4). 259–266. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026